Middle East & Africa Tumor Profiling Market Size & Outlook
The tumor profiling market in Middle East & Africa is expected to reach a projected revenue of US$ 764.2 million by 2030. A compound annual growth rate of 8.3% is expected of Middle East & Africa tumor profiling market from 2025 to 2030.
Revenue, 2024 (US$M)
$473.0
Forecast, 2030 (US$M)
$764.2
CAGR, 2025 - 2030
8.3%
Report Coverage
Middle East & Africa
Related Markets
MEA tumor profiling market highlights
- The MEA tumor profiling market generated a revenue of USD 473.0 million in 2024.
- The market is expected to grow at a CAGR of 8.3% from 2025 to 2030.
- In terms of segment, genomics was the largest revenue generating technique in 2024.
- Epigenetics is the most lucrative technique segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 473.0 million |
| Market revenue in 2030 | USD 764.2 million |
| Growth rate | 8.3% (CAGR from 2025 to 2030) |
| Largest segment | Genomics |
| Fastest growing segment | Epigenetics |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetics, Proteomics, Metabolomics, Genomics |
| Key market players worldwide | Illumina Inc, Qiagen NV, NeoGenomics Inc, Bruker Corp, Guardant Health Inc, Foundation Medicine |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.9% of the global tumor profiling market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,411.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tumor Profiling Market Scope
Tumor profiling market segmentation & scope
Tumor Profiling Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| NeoGenomics Inc | View profile | 2100 | 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 | https://www.neogenomics.com |
| Foundation Medicine | View profile | 251-500 | Cambridge, Massachusetts, United States, North America | http://www.foundationmedicine.com |
| Bruker Corp | View profile | 9707 | 40 Manning Road, Billerica, MA, United States, 01821 | https://www.bruker.com |
| Guardant Health Inc | View profile | 1779 | 3100 Hanover Street, Palo Alto, CA, United States, 94304 | https://www.guardanthealth.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
MEA tumor profiling market size, by country, 2018-2030 (US$M)
Middle East & Africa Tumor Profiling Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
